Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Down 58.7% in August

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a significant drop in short interest during the month of August. As of August 14th, there was short interest totaling 108,801 shares, a drop of 58.7% from the July 30th total of 263,441 shares. Based on an average daily volume of 13,826,443 shares, the short-interest ratio is presently 0.0 days. Currently, 11.9% of the company’s stock are short sold.

Autonomix Medical Price Performance

Shares of AMIX stock opened at $5.63 on Friday. The company has a fifty day moving average price of $6.39 and a two-hundred day moving average price of $7.57. Autonomix Medical has a one year low of $2.44 and a one year high of $32.55. The stock has a market cap of $5.46 million, a P/E ratio of -0.14 and a beta of -1.17.

Autonomix Medical (NASDAQ:AMIX) last released its quarterly earnings data on Wednesday, August 12th. The company reported ($5.02) earnings per share for the quarter, topping the consensus estimate of ($6.40) by $1.38. As a group, equities research analysts anticipate that Autonomix Medical will post -20.17 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AMIX has been the topic of a number of research reports. Zacks Research raised shares of Autonomix Medical to a “hold” rating in a research report on Tuesday, June 2nd. Weiss Ratings raised shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research report on Tuesday, July 28th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Autonomix Medical has a consensus rating of “Hold” and a consensus target price of $42.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.